Webinar Summary
- Learn how to use DC/CD8+ T cell co-culture to study the antigen-specific responses of CD8+ T cells, including their activation, proliferation, cytokine production, and cytotoxic killing activity.
- Explore the features of STEMCELL's ImmunoCult Medium and Activators.
- Isolate antigen-specific cells with EasySep Release.
Webinar Topics
STEMCELL Technologies Inc.
Who Should Attend?
Scientist.com
Presenters

Catherine Ewen
Dr. Catherine Ewen works as a Senior Scientist at STEMCELL Technologies, where she brings proof-of-concept products to market. She is passionate about scientific discovery and technological advancements, and her top goal has always been to build effective and collaborative teams that are driven by innovation and pursue scientific excellence.
Sponsor

STEMCELL Technologies Inc.
Content Partners

Scientist.com
Scientist.com is the world’s largest and first platform built for the intricacies of scientific outsourcing.
We help pharmaceutical and biotechnology organizations discover, engage, manage, and scale relationships with the providers that support every stage of the pipeline—from discovery and preclinical research to clinical development, manufacturing, medical affairs, and commercialization. Through a centralized platform, organizations can access a global network of 6,000+ providers, streamline sourcing and procurement workflows, maintain compliance, manage supplier relationships, and leverage data-driven insights to make faster, more informed decisions.
Today, Scientist.com supports more than 130 life science organizations, including 24 of the world's top 30 pharmaceutical companies, helping teams reduce operational complexity, accelerate timelines, and bring innovations to patients faster. Our mission is to make it possible to cure all human disease by 2050.

























































